Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

TGEN

Tecogen (TGEN)

Tecogen Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TGEN
일자시간출처헤드라인심볼기업
2006/06/2220:30Business WireInterim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the European Rheumatology Meeting; ResulNASDAQ:TGENTecogen Inc
2006/06/1420:30Business WireTargeted Genetics to Present at the Needham & Company Fifth Annual Biotechnology and Medical Technology ConferenceNASDAQ:TGENTecogen Inc
2006/05/0920:30Business WireTargeted Genetics' Shareholders Authorize Reverse Stock Split; Board of Directors Set One-for-Ten Split RatioNASDAQ:TGENTecogen Inc
2006/05/0820:30Business WireTargeted Genetics to Present at the Rodman & Renshaw 3rd Annual Global Healthcare ConferenceNASDAQ:TGENTecogen Inc
2006/05/0220:30Business WireTargeted Genetics Reports First Quarter 2006 Financial ResultsNASDAQ:TGENTecogen Inc
2006/04/2620:30Business WireZambia Begins First Preventive HIV Vaccine TrialNASDAQ:TGENTecogen Inc
2006/04/2006:00Business WireTargeted Genetics to Host Conference Call and Webcast Discussion of First Quarter 2006 Results on May 2, 2006NASDAQ:TGENTecogen Inc
2006/04/0420:30Business WireTargeted Genetics Executives to Participate in Panel Discussions as Part of the 14th Annual BIO 2006 Annual International ConveNASDAQ:TGENTecogen Inc
2006/03/1621:30Business WireTargeted Genetics Amends tgAAC94 Clinical Protocol and Advances Ongoing Trial to Phase I/II; Amendment Potentially AcceleratesNASDAQ:TGENTecogen Inc
2006/03/1421:30Business WireTargeted Genetics Completes $5.0 Million Public Offering of Common StockNASDAQ:TGENTecogen Inc
2006/03/1020:00Business WireTargeted Genetics Announces $5.0 Million Public Offering of Common StockNASDAQ:TGENTecogen Inc
2006/03/0918:00Business WireTargeted Genetics Reports Fourth Quarter and Year-End 2005 Financial ResultsNASDAQ:TGENTecogen Inc
2006/03/0104:34Business WireTargeted Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-Ended 2005 Results on March 9, 2006NASDAQ:TGENTecogen Inc
2006/02/1021:30Business WireTargeted Genetics Strengthens Intellectual Property for AAV Vector Manufacturing ProcessesNASDAQ:TGENTecogen Inc
2006/02/0821:30Business WireTargeted Genetics to Webcast Presentation at the 8th Annual BIO CEO & Investor Conference on February 14, 2006NASDAQ:TGENTecogen Inc
2006/02/0702:06Business WireThe Uganda Virus Research Institute (UVRI), in collaboration with the International AIDS Vaccine Initiative (IAVI) and TargetedNASDAQ:TGENTecogen Inc
2006/01/2621:30Business WireTargeted Genetics Strengthens Intellectual Property for AAV Vector Manufacturing Purification ProcessesNASDAQ:TGENTecogen Inc
2006/01/2506:30Business WireTargeted Genetics Announces Strategic Restructuring to Reduce Expenses and Advance Lead Inflammatory Arthritis Product CandidateNASDAQ:TGENTecogen Inc
2006/01/1905:02Business WireTargeted Genetics Appoints David J. Poston as Chief Financial OfficerNASDAQ:TGENTecogen Inc
2005/12/0723:00PR Newswire (US)Celladon Secures $30 Million in Series B FinancingNASDAQ:TGENTecogen Inc
2005/11/1503:49Business WireIAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test Targeted Genetics' HIV Vaccine CandidateNASDAQ:TGENTecogen Inc
2005/11/0321:30Business WireTargeted Genetics Reports Third Quarter Financial ResultsNASDAQ:TGENTecogen Inc
2005/11/0221:30Business WireTargeted Genetics to Present at the Rodman & Renshaw TechVest 7th Annual Healthcare ConferenceNASDAQ:TGENTecogen Inc
2005/11/0121:30Business WireTargeted Genetics Announces Appointment of Michael S. Perry, 18 Year Biotechnology/Pharmaceutical Industry Veteran, to Its BoardNASDAQ:TGENTecogen Inc
2005/10/3121:30Business WireTargeted Genetics Presents Additional Data from Its Inflammatory Arthritis Program at the 13th Annual Congress of the European SNASDAQ:TGENTecogen Inc
2005/10/2520:30Business WireTargeted Genetics to Release Financial Results and Host Webcast on Thursday, November 3, 2005NASDAQ:TGENTecogen Inc
2005/10/1900:48Business WireTargeted Genetics to Present At 2005 BIO InvestorForumNASDAQ:TGENTecogen Inc
2005/10/1120:30Business WireTargeted Genetics Initiates Next Clinical Trial of tgAAC94 in Inflammatory ArthritisNASDAQ:TGENTecogen Inc
2005/10/0421:43PR Newswire (US)Sirna Therapeutics Granted Broad Patent Covering siRNAs Targeting Huntington's DiseaseNASDAQ:TGENTecogen Inc
2005/09/0205:30Business WireTargeted Genetics Restructures Biogen DebtNASDAQ:TGENTecogen Inc
 검색 관련기사 보기:NASDAQ:TGEN